Marshall Wace’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.6M Sell
157,818
-25,889
-14% -$3.74M 0.02% 619
2026
Q1
$21.7M Buy
183,707
+176,329
+2,390% +$23.1M 0.02% 679
2025
Q4
$878K Buy
+7,378
New +$840K ﹤0.01% 2000
2025
Q2
Sell
-62,384
Closed -$7.98M 3018
2025
Q1
$7.98M Buy
+62,384
New +$8.97M 0.01% 860
2024
Q1
Sell
-14,732
Closed -$2.48M 2695
2023
Q4
$2.48M Buy
+14,732
New +$2.15M ﹤0.01% 1131
2021
Q2
Sell
-23,497
Closed -$3.1M 2938
2021
Q1
$3.1M Sell
23,497
-4,099
-15% -$539K 0.01% 1095
2020
Q4
$3.26M Sell
27,596
-46,473
-63% -$5.42M 0.02% 735
2020
Q3
$7.8M Buy
74,069
+33,015
+80% +$3.49M 0.05% 374
2020
Q2
$4.38M Buy
+41,054
New +$3.81M 0.03% 517

Other funds holding NOVT

Marshall Wace's NOVT Position: Q2 2026 in Review

Marshall Wace reduced its Novanta (NOVT) stake by 14% in Q2 2026, selling an estimated $3.74M and leaving 157,818 shares worth $25.6M. The position accounts for 0.02% of the portfolio, ranked #619.

Marshall Wace first reported a position in NOVT in Q2 2020 and has held it in 9 quarters since. 390 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Marshall Wace held 157,818 shares of Novanta worth $25.6M as of Q2 2026.
  • Marshall Wace sold 25,889 Novanta shares in Q2 2026, an estimated $3.74M.
  • Novanta made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #619 holding.
  • Marshall Wace first reported a position in Novanta in Q2 2020 and has held it in 9 quarters since.
  • 390 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.